Publiserte artikler 2022
Mazzawi T, Hausken T, Refsnes PF, Hatlebakk JG, Lied GA The Effect of Anaerobically Cultivated Human Intestinal Microbiota Compared to Fecal Microbiota Transplantation on Gut Microbiota Profile and Symptoms of Irritable Bowel Syndrome, a Double-Blind Placebo-Controlled Study. Microorganisms 2022 Sep 11;10(9). Epub 2022 sep 11.
Castro Tejera V, Öhman L, Aabakken L, Fellström B, Hausken T, Hovde Ø, Hreinsson JP, Lindberg G, Venge P, Simrén M, Törnblom H Randomised clinical trial and meta-analysis: mesalazine treatment in irritable bowel syndrome-effects on gastrointestinal symptoms and rectal biomarkers of immune activity. Aliment Pharmacol Ther 2022 Sep;56(6):968. Epub 2022 aug 8.
El-Salhy M, Winkel R, Casen C, Hausken T, Gilja OH, Hatlebakk JG Efficacy of Fecal Microbiota Transplantation for Patients With Irritable Bowel Syndrome at 3 Years After Transplantation. Gastroenterology 2022 Oct;163(4):982. Epub 2022 jun 14.
El-Salhy M, Mazzawi T, Hausken T, Hatlebakk JG The fecal microbiota transplantation response differs between patients with severe and moderate irritable bowel symptoms. Scand J Gastroenterol 2022 Sep;57(9):1036. Epub 2022 apr 29.
El-Salhy M, Mazzawi T, Hausken T, Hatlebakk JG Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation. Neurogastroenterol Motil 2022 Sep;34(9):e14353. Epub 2022 mar 18.
Mazzawi T, Hausken T, El-Salhy M Changes in colonic enteroendocrine cells of patients with irritable bowel syndrome following fecal microbiota transplantation. Scand J Gastroenterol 2022 Jul;57(7):792. Epub 2022 feb 14.
Hillestad EMR, van der Meeren A, Nagaraja BH, Bjørsvik BR, Haleem N, Benitez-Paez A, Sanz Y, Hausken T, Lied GA, Lundervold A, Berentsen B Gut bless you: The microbiota-gut-brain axis in irritable bowel syndrome. World J Gastroenterol 2022 Jan 28;28(4):412.
Jensen C, Antonsen MF, Lied GA Gut Microbiota and Fecal Microbiota Transplantation in Patients with Food Allergies: A Systematic Review. Microorganisms 2022 Sep 26;10(10). Epub 2022 sep 26.
Teige, ES; Hillestad, EMR; Steinsvik, EK; Brønstad, I; Bjørkevoll, M; Straume, MG; Rasmussen, SH; Bjørsvik, BR; Haleem, M; Lundervold, A; Valeur, J; Hausken, T; Berentsen, B; Lied, GA. Bergen Braingut Study: Relations between fecal microbiota profile and its metabolites (short-chain fatty acids) and symptoms in irritable bowel syndrome. United European Gastroenterology journal 2022 ;Volum 10. Suppl. 8 s. 412-412.